175 related articles for article (PubMed ID: 30410358)
21. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
22. [Clinical Characteristics and Prognostic Factors of Lung Adenosquamous Carcinoma
in SEER Database between 2010 and 2015].
Zhan C; Jiang T; Yang X; Guo W; Tan L
Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):600-609. PubMed ID: 30172267
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma].
Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414
[No Abstract] [Full Text] [Related]
24. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S
Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
[TBL] [Abstract][Full Text] [Related]
25. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
26. Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.
Young GD; Winokur TS; Cerfolio RJ; Van Tine BA; Chow LT; Okoh V; Garver RI
Lung Cancer; 2002 May; 36(2):133-41. PubMed ID: 11955647
[TBL] [Abstract][Full Text] [Related]
27. Prognosis and survival after radical resection of primary adenosquamous lung carcinoma.
Gawrychowski J; Bruliński K; Malinowski E; Papla B
Eur J Cardiothorac Surg; 2005 Apr; 27(4):686-92. PubMed ID: 15784375
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features and prognosis of gastric adenosquamous carcinoma.
Feng F; Zheng G; Qi J; Xu G; Wang F; Wang Q; Guo M; Lian X; Zhang H
Sci Rep; 2017 Jul; 7(1):4597. PubMed ID: 28676632
[TBL] [Abstract][Full Text] [Related]
29. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
[TBL] [Abstract][Full Text] [Related]
30. Prothymosin-α and parathymosin expression predicts poor prognosis in squamous and adenosquamous carcinomas of the gallbladder.
Chen K; Xiong L; Yang Z; Huang S; Zeng R; Miao X
Oncol Lett; 2018 Apr; 15(4):4485-4494. PubMed ID: 29541218
[TBL] [Abstract][Full Text] [Related]
31. Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder.
Shi Z; Huang Q; Chen J; Yu P; Wang X; Qiu H; Chen Y; Dong Y
Am J Transl Res; 2015; 7(10):2015-25. PubMed ID: 26692945
[TBL] [Abstract][Full Text] [Related]
32. Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy.
Cooke DT; Nguyen DV; Yang Y; Chen SL; Yu C; Calhoun RF
Ann Thorac Surg; 2010 Sep; 90(3):943-8. PubMed ID: 20732522
[TBL] [Abstract][Full Text] [Related]
33. Adenosquamous carcinoma of the digestive system: a literature review.
Li HS; He T; Yang LL
Scand J Gastroenterol; 2020 Nov; 55(11):1268-1276. PubMed ID: 33070641
[TBL] [Abstract][Full Text] [Related]
34. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
35. Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma.
Watanabe Y; Shiraishi K; Takahashi F; Yoshida A; Suzuki K; Asamura H; Takeuchi M; Furuta K; Tsuta K
Histopathology; 2015 Jun; 66(7):939-48. PubMed ID: 25257380
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.
Guo Y; Jia L; Shao GG; Sun HW; Wang XX; Wang GJ; Ma KW
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):350-355. PubMed ID: 26072072
[TBL] [Abstract][Full Text] [Related]
37. [The clinical and pathological features, biomarker characteristics and prognosis analysis of lung adenosquamous carcinoma].
Zhou SY; Xue Q; Ying JM; Hu XS; Yang JL; Lin H; Shi YK
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):50-55. PubMed ID: 30678417
[No Abstract] [Full Text] [Related]
38. [Clinicopathologic Features and Prognostic Implications in 72 Cases
with Lung Adenosquamous Carcinoma].
Wu X; Li J; Chen S; Yu L; Yang B
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):653-658. PubMed ID: 27760593
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
40. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Pathol Oncol Res; 2019 Jan; 25(1):157-167. PubMed ID: 29043607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
